🇨🇦 Hu38Sb19 in Canada

Hu38Sb19 (isatuximab) regulatory status in Canada.

Marketing authorisation

Health Canada

  • Status: likely_approved

Hu38Sb19 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Canada

Frequently asked questions

Is Hu38Sb19 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Hu38Sb19 in Canada?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.